NIH – U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)

1/10/2019

Note:  participating Institutes:  NCI, NEI, NIEHS, NIMH, NINDS The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and clinical research between United States…

NIH/NCCIH – Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01, R21 Clinical Trial Optional)

1/10/2019

The following description was taken from the R01 version of this FOA. The management of pain has often relied on opioid-based, pharmacologic interventions, which not only lack long-term efficacy but…

NIH – End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)

1/10/2019

The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the…

NIH – Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

1/10/2019

This Funding Opportunity Announcement (FOA), Stimulating Hematology Investigation:  New Endeavors (SHINE) is intended to promote and support innovative, high-quality hematology research relevant to the missions of the National Institute of Diabetes…

NIH/NEI – NEI Audacious Goals Initiative: Preliminary Studies for Translation-Enabling Models of the Visual System (R21 Clinical Trial Not Allowed)

1/10/2019

The National Eye Institute (NEI) Audacious Goal Initiative (AGI) was launched in 2012 with an open competition for bold, new ideas to stimulate innovation in establishing a national vision research…

NIH/NIDA – Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders (UG1 Clinical Trials Required)

1/10/2019

The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the clinical development of medications to treat Substance Use Disorders (SUDs) by establishing Laboratories with the expertise and resources…

NIH/NCI – NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00, two opportunities)

1/10/2019

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed) (RFA-CA-19-029) NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00…

DOD – Breast Cancer Research Program

1/9/2019

Defense Health Program Department of Defense Breast Cancer Research Program Funding Opportunities for Fiscal Year 2019 (FY19) The FY19 Defense Appropriation provides $130 million (M) to the Department of Defense…

NIH – Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 and R43/R44 – Clinical Trial Not Allowed)

1/8/2019

Purpose: Contemporary science evaluates and is also subject to evaluation. Assessment of research is increasingly becoming an integral part of any scientific activity. Among the reasons for such attention is…